Refine by
Patient Access Articles & Analysis
332 news found
These internationally recognized standards, developed and published by the world’s most recognized standards organization for information security management systems, underscore the Company’s commitment to maintaining the highest standards of security and data protection for its customers and the patients they serve. SOPHiA GENETICS has consistently prioritized the ...
Overall, the freeze-dried rapid-release formulations by Protheragen-ING offer several benefits: l They enhance the drug’s stability, prolong its shelf life, and boost its bioavailability. l These formulations allow the medication to be absorbed into the body at a regulated release rate, leading to improved therapeutic outcomes. l They make drug therapy more accessible for ...
With sonolucent cranial plates, improvements in ultrasound image quality, and ultrasound training in neurosurgeon training programs, the ability to see inside the cranial compartment can be conducted in real time in any location with access to ultrasound equipment. This new capability can help assess relevant intracranial and intraventricular anatomy to help Neurosurgeons manage ...
EGFR is a biomarker that presents in some patients with NSCLC and that has specific targeted therapies associated with it. ...
ByTempus
Patient Access to Trudhesa® to Continue Uninterrupted Sufficient Liquidity to Fund Day to Day Operations During Court-Supervised Process Impel Pharmaceuticals Inc. ...
The program is available across the United States, enabling nationwide access to DYANAVEL XR extended-release tablets. Patients and physicians wishing to access the DYANAVEL Delivered program can learn more at www.dyanavel.com/delivered. “This partnership underscores our continued commitment to ensuring patients have ...
Dyadic is a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and unmet clinical needs for effective, affordable, and accessible biopharmaceutical products and alternative proteins for human and animal health. bYoRNA is a French biotechnology company focused on producing affordable ...
This is a testament to each member’s commitment to Tevogen’s patient-centric approach of merging affordability with advanced science — a blueprint for sustainable success in the upcoming era of medicine.” Tevogen Bio is a clinical-stage specialty immunotherapy company harnessing one of nature’s most powerful immunological weapons, CD8+ cytotoxic T ...
JUNE Medical is delighted to announce a new agreement with a major US hospital group to supply the award-winning Galaxy II® self-retaining surgical retractors to over 1,600 hospitals in the US, commencing April 15, 2023. This game-changing device radically improves the safety and ease of surgical retraction for both patients and medical staff; its ergonomic design transforms the way in which ...
“Bayer is committed to improving health outcomes for people living with prostate cancerand that as many eligible patients as possible gain access to Nubeqa.” The approval is based on the positive results from the Phase III ARASENS trial, which demonstrated that darolutamide plus androgen deprivation therapy (ADT) in combination with docetaxel ...
ByBayer AG
The completion of the facility will accelerate patient access to the new drug, and improve the prevention and and treatment of HIV infection in the region. ...
Stemline is committed to helping patients access ORSERDU and will be offering services to overcome access barriers. ...
“With darolutamide’s unprecedented survival data and minimal disruption to patients´ daily living across both mHSPC and high risk nmCRPC, following regulatory approval, we will be working to ensure that as many patients as possible benefit from darolutamide. ...
ByBayer AG
Our clinics, urgent care/immediate access centers, and hospitalist program remain open during this time to serve the community with any medical needs they may have. This community, one we are proud to have been a part of for over 30 years, is extraordinarily strong and resilient, and by standing united, we can build towards a future where no one must experience such senseless ...
By initiating the collaboration at Gastro One, the organizations are taking initial steps to develop a hub and spoke recruitment model for One GI®, which will democratize access to the novel IBD therapeutics for all patients, regardless of where they receive care. ...
As part of our longstanding commitment to supporting numerous relief efforts around the world, LifeScan is working with the non-profit humanitarian organization, Direct Relief, to respond to the urgent need to supply much-needed blood glucose testing supplies to the many Ukrainians now without access to critical health products. We have also taken steps to help ensure continued ...
ByLifeScan
Through this collaboration, xCures will help eligible pancreatic cancer patients access a Phase III clinical study entitled, Targeted Intra-arterial Gemcitabine vs. ...
ByxCures
“Our shared mission with Iterative Health to democratize access to the highest quality GI care has opened the door for us to utilize AIR in our practices,” said Joseph Garcia, CEO of Gastro Health. ...
“This increasingly global cohort, representing more than 18 countries across five continents, is not only driving better patient outcomes, but making healthcare more accessible. We are excited to follow the meaningful impact and continued success of this year’s ...
This award demonstrates the tremendous effort our team puts in everyday to develop technology that will benefit patients everywhere.” Iterative Health was selected from a pool of over 13,000 private companies and was chosen based on its R&D activity, market potential, business relationships, investor profile, competitive landscape, team strength, and tech novelty. ...